Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1195701017 | Co-amoxiclav 125mg/31mg chewable tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1209143012 | Co-amoxiclav 125mg/31mg chewable tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2572371012 | Amoxicillin + clavulanate potassium 125mg/31mg chewable tablet (product) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2576144019 | Amoxicillin + clavulanate potassium 125mg/31mg chewable tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2579484017 | Amoxicillin + clavulanic acid 125mg/31mg chewable tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763899015 | Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763900013 | Product containing precisely amoxicillin 125 milligram and clavulanic acid (as clavulanate potassium) 31.2 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3364881000052117 | amoxicillin 125 mg + kaliumklavulanat 31 mg, tuggtablett | sv | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| 4536031000052110 | amoxicillin 125 milligram och klavulansyra (som kaliumklavulanat) 31,2 milligram, tuggtablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Is a | amoxicillin med kaliumklavulanat | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Is a | Amoxicillin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Is a | amoxicillin med kaliumklavulanat för oralt bruk | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has active ingredient | Amoxycillin with clavulanate potassium | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has active ingredient | Amoxicillin (substance) | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has active ingredient | Clavulanate potassium (substance) | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has manufactured dose form | Chewable tablet | true | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Is a | Beta-lactam antibacterial agent | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has precise active ingredient | Amoxicillin (substance) | true | Inferred relationship | Some | 1 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has basis of strength substance (attribute) | Amoxicillin (substance) | true | Inferred relationship | Some | 1 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has basis of strength substance (attribute) | Clavulanic acid (substance) | true | Inferred relationship | Some | 2 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | har täljarvärde som visar styrka | 31.2 | false | Inferred relationship | Some | 2 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Is a | Amoxicillin and clavulanic acid only product in oral dose form | true | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | har täljarvärde som visar styrka | 125 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has precise active ingredient | Clavulanate potassium (substance) | true | Inferred relationship | Some | 2 | |
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR